{{Rsnum
|rsid=842647
|Gene=REL
|Chromosome=2
|position=60892336
|Orientation=plus
|GMAF=0.4826
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=REL
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 48.2 | 41.1 | 10.7
| HCB | 2.2 | 31.4 | 66.4
| JPT | 2.7 | 31.0 | 66.4
| YRI | 29.3 | 48.3 | 22.4
| ASW | 45.6 | 47.4 | 7.0
| CHB | 2.2 | 31.4 | 66.4
| CHD | 3.7 | 22.2 | 74.1
| GIH | 12.9 | 43.6 | 43.6
| LWK | 46.8 | 45.9 | 7.3
| MEX | 31.0 | 50.0 | 19.0
| MKK | 72.4 | 26.9 | 0.6
| TSI | 50.5 | 42.6 | 6.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=19240061
|Title=Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling
}}

{{PMID Auto
|PMID=22087237
|Title=Improving the estimation of celiac disease sibling risk by non-HLA genes
|OA=1
}}

{{PMID Auto
|PMID=18439550
|Title=Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP.
|OA=1
}}

{{PMID Auto
|PMID=18466468
|Title=Analysis of variation in NF-kappaB genes and expression levels of NF-kappaB-regulated molecules.
|OA=1
}}

{{PMID Auto
|PMID=24871462
|Title=Coeliac disease-associated polymorphisms influence thymic gene expression
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}